Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

Projects / Programmes source: ARIS

DIAGNOSTIC VALUE OF PROCALCITONIN AT PELVIC INFALMMATORY DISEASE

Edit
Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   

Code Science Field
B500  Biomedical sciences  Immunology, serology, transplantation 
Keywords
prokalcitonin, pelvic infalmmatory disease
Evaluation (rules)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Researchers (6)
no. Code Name and surname Research area Role Period No. of publications
1.  20133  Nina Čas Sikošek  Oncology  Researcher  2003 - 2005  85 
2.  03457  PhD Borut Gorišek  Oncology  Head  2003 - 2005  254 
3.  23380  PhD Nina Gorišek Miksić  Microbiology and immunology  Researcher  2003 - 2005  110 
4.  23382  Anka Horvat    Technical associate  2003 - 2005  0 
5.  23383  Božena Rodeš    Technical associate  2003 - 2005  4 
6.  01324  PhD Iztok Takač  Human reproduction  Researcher  2003 - 2005  911 
Organisations (1)
no. Code Research organisation City Registration number No. of publications
1.  0334  University Medical Centre Maribor  Maribor  5054150000  22,743 
Abstract
Pelvic inflammatory disease are common cause or fertility problems of young women. For effective treatment it is of major importance following the dynamic of pathology process. Procalcitonin in new marker that was found doubtlessly useful in diagnostics of sepsis. We want to investigate if procalcitonin would help in more effective tracing of pelvic inflammatory disease. It would also rationalise the treatment in terms of costs, time efficiency and effectivness. In our study we will analyse the dynamic of serum procalcitonin level in group of patients with pelvic inflammation disease from the beginning of the treatment to normalisation of all clinical and laboratory parameters of inflamation. We will also analyse procalcitonin level at a group of patients after a major pelvic surgery and at a group of healthy women as s control group. With this study we would like to define precisely the sensitivity, specificy and positive and negative predictive value of procalcitonin in pelvic inflammatory disease.
Confirmation required
Views history
Favourite